-
1
-
-
0026457407
-
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction
-
Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992 52 : 453 457.
-
(1992)
Clin Pharmacol Ther
, vol.52
, pp. 453-457
-
-
Hebert, M.F.1
Roberts, J.P.2
Prueksaritanont, T.3
Benet, L.Z.4
-
2
-
-
0029123393
-
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine
-
Gomez DY, Wacher VJ, Tomlanovich SJ, Hebert MF, Benet LZ. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 1995 58 : 15 9.
-
(1995)
Clin Pharmacol Ther
, vol.58
, pp. 15-9
-
-
Gomez, D.Y.1
Wacher, V.J.2
Tomlanovich, S.J.3
Hebert, M.F.4
Benet, L.Z.5
-
3
-
-
0028820208
-
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine
-
Wu C-Y, Benet LZ, Hebert MF, Gupta SK, Rowland M, Gomez DY et al. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 1995 58 : 492 497.
-
(1995)
Clin Pharmacol Ther
, vol.58
, pp. 492-497
-
-
Wu, C.-Y.1
Benet, L.Z.2
Hebert, M.F.3
Gupta, S.K.4
Rowland, M.5
Gomez, D.Y.6
-
4
-
-
0030742705
-
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole
-
Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther 1997 62 : 41 9.
-
(1997)
Clin Pharmacol Ther
, vol.62
, pp. 41-9
-
-
Floren, L.C.1
Bekersky, I.2
Benet, L.Z.3
Mekki, Q.4
Dressler, D.5
Lee, J.W.6
-
5
-
-
0032895989
-
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers
-
Hebert MF, Fisher RM, Marsh CL, Dressler D, Berkersky I. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 1999 39 : 91 6.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 91-6
-
-
Hebert, M.F.1
Fisher, R.M.2
Marsh, C.L.3
Dressler, D.4
Berkersky, I.5
-
6
-
-
0001319826
-
Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole
-
Floren LC, Christians U, Zimmerman JJ, Neefe L, Schorer R, Rushworth D et al. Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole. Clin Pharmacol Ther 1999 65 : 159.
-
(1999)
Clin Pharmacol Ther
, vol.65
, pp. 159
-
-
Floren, L.C.1
Christians, U.2
Zimmerman, J.J.3
Neefe, L.4
Schorer, R.5
Rushworth, D.6
-
7
-
-
17644380257
-
Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a Biopharmaceutics Drug Disposition Classification System
-
Wu C-Y, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a Biopharmaceutics Drug Disposition Classification System. Pharm Res 2005 22 : 11 23.
-
(2005)
Pharm Res
, vol.22
, pp. 11-23
-
-
Wu, C.-Y.1
Benet, L.Z.2
-
8
-
-
0028948839
-
A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
-
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995 12 : 413 420.
-
(1995)
Pharm Res
, vol.12
, pp. 413-420
-
-
Amidon, G.L.1
Lennernäs, H.2
Shah, V.P.3
Crison, J.R.4
-
10
-
-
62649128592
-
The use of drug metabolism for prediction of intestinal permeability (dagger)
-
Chen ML, Yu L. The use of drug metabolism for prediction of intestinal permeability (dagger). Mol Pharmaceut 2009 6 : 74 81.
-
(2009)
Mol Pharmaceut
, vol.6
, pp. 74-81
-
-
Chen, M.L.1
Yu, L.2
-
11
-
-
77149132279
-
Use of drug metabolism and Caco-2 transport for prediction of intestinal permeability revisited using accepted scientific definitions vs. an FDA surrogate
-
In press).
-
Larregieu CA, Benet LZ. Use of drug metabolism and Caco-2 transport for prediction of intestinal permeability revisited using accepted scientific definitions vs. an FDA surrogate. Mol Pharmaceut 2009 In press).
-
(2009)
Mol Pharmaceut
-
-
Larregieu, C.A.1
Benet, L.Z.2
-
12
-
-
35648978876
-
The use of BDDCS in classifying the permeability of marketed Drugs
-
Benet LZ, Amidon GL, Barends DM, Lennernäs H, Polli JE, Shah VP et al. The use of BDDCS in classifying the permeability of marketed Drugs. Pharm Res 2008 52 : 483 488.
-
(2008)
Pharm Res
, vol.52
, pp. 483-488
-
-
Benet, L.Z.1
Amidon, G.L.2
Barends, D.M.3
Lennernäs, H.4
Polli, J.E.5
Shah, V.P.6
-
13
-
-
67649932264
-
-
European Medicines Agency. CPMP/WEP/QWP/1401/98. European Medicines Agency Web site (July 2008). 2008: Retrieved from
-
European Medicines Agency. Guideline on the investigation of bioequivalence. CPMP/WEP/QWP/1401/98. European Medicines Agency Web site (July 2008). 2008: Retrieved from http://www.emea.europa.eu/pdfs/human/qwp/ 140198enrev1.pdf.
-
Guideline on the Investigation of Bioequivalence.
-
-
-
14
-
-
0035054725
-
The gut as a barrier to drug absorption
-
Zhang Y, Benet LZ. The gut as a barrier to drug absorption. Clin Pharmacokinet 2001 40 : 159 168.
-
(2001)
Clin Pharmacokinet
, vol.40
, pp. 159-168
-
-
Zhang, Y.1
Benet, L.Z.2
-
15
-
-
0142212163
-
Disposition of tacrolimus in isolated perfused rat liver: Influence of troleandomycin, cyclosporine, and GG918
-
Wu C-Y, Benet LZ. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and GG918. Drug Metab Dispos 2003 31 : 1292 1295.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 1292-1295
-
-
Wu, C.-Y.1
Benet, L.Z.2
-
16
-
-
1342302110
-
Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: Hepatic enzyme-transporter interplay
-
Lau YY, Wu C-Y, Okochi H, Benet LZ. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. J Pharmacol Exp Ther 2004 308 : 1040 1045.
-
(2004)
J Pharmacol Exp Ther
, vol.308
, pp. 1040-1045
-
-
Lau, Y.Y.1
Wu, C.-Y.2
Okochi, H.3
Benet, L.Z.4
-
17
-
-
0142106303
-
Transporter-enzyme interactions: Implications for predicting drug-drug interactions from in vitro data
-
Benet LZ, Cummins CL, Wu C-Y. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. Curr Drug Metab 2003 4 : 393 398.
-
(2003)
Curr Drug Metab
, vol.4
, pp. 393-398
-
-
Benet, L.Z.1
Cummins, C.L.2
Wu, C.-Y.3
-
18
-
-
0029028792
-
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
-
Wacher VJ, Wu C-Y, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995 13 : 129 134.
-
(1995)
Mol Carcinog
, vol.13
, pp. 129-134
-
-
Wacher, V.J.1
Wu, C.-Y.2
Benet, L.Z.3
-
19
-
-
31144438802
-
Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems
-
Lau YY, Okochi H, Huang Y, Benet LZ. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharmacol Exp Ther 2006 316 : 762 771.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 762-771
-
-
Lau, Y.Y.1
Okochi, H.2
Huang, Y.3
Benet, L.Z.4
-
20
-
-
33745230031
-
Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: Relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism
-
Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metab Dispos 2006 34 : 1175 1181.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 1175-1181
-
-
Lau, Y.Y.1
Okochi, H.2
Huang, Y.3
Benet, L.Z.4
-
21
-
-
33846571368
-
Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers
-
Lau YY, Huang Y, Frassetto L, Benet LZ. Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther 2007 81 : 194 204.
-
(2007)
Clin Pharmacol Ther
, vol.81
, pp. 194-204
-
-
Lau, Y.Y.1
Huang, Y.2
Frassetto, L.3
Benet, L.Z.4
-
22
-
-
0032793959
-
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999 27 : 866 871.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
23
-
-
41549098278
-
Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide
-
Ishiguro N, Maeda K, Saito A, Kishimoto W, Matsushima S, Ebner T et al. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Drug Metab Dispos 2008 36 : 796 805.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 796-805
-
-
Ishiguro, N.1
Maeda, K.2
Saito, A.3
Kishimoto, W.4
Matsushima, S.5
Ebner, T.6
-
24
-
-
52949104006
-
Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin
-
Kitamura S, Maeda K, Wang Y, Sugiyama Y. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 2008 36 : 2014 2023.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 2014-2023
-
-
Kitamura, S.1
Maeda, K.2
Wang, Y.3
Sugiyama, Y.4
-
25
-
-
0031662109
-
5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter
-
Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP et al. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res 1998 15 : 1154 1159.
-
(1998)
Pharm Res
, vol.15
, pp. 1154-1159
-
-
Han, H.1
De Vrueh, R.L.2
Rhie, J.K.3
Covitz, K.M.4
Smith, P.L.5
Lee, C.P.6
-
26
-
-
23844467048
-
Amino acid ester prodrugs of the anticancer agent gemcitabine: Synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport
-
Song X, Lorenzi PL, Landowski CP, Vig BS, Hilfinger JM, Amidon GL. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport. Mol Pharmaceut 2005 2 : 157 167.
-
(2005)
Mol Pharmaceut
, vol.2
, pp. 157-167
-
-
Song, X.1
Lorenzi, P.L.2
Landowski, C.P.3
Vig, B.S.4
Hilfinger, J.M.5
Amidon, G.L.6
-
27
-
-
68149170038
-
The role of transporters in the pharmacokinetics of orally administered drugs
-
Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 2009 26 : 2039 2054.
-
(2009)
Pharm Res
, vol.26
, pp. 2039-2054
-
-
Shugarts, S.1
Benet, L.Z.2
-
28
-
-
39149115065
-
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
-
Custodio JM, Wu C-Y, Benet LZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 2008 60 : 717 733.
-
(2008)
Adv Drug Deliv Rev
, vol.60
, pp. 717-733
-
-
Custodio, J.M.1
Wu, C.-Y.2
Benet, L.Z.3
|